Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × antineoplaston AS 2-1 × Clear all

NCT00003532 2017-12-12

Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Ovarian Cancer

Phase 2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms